Literature DB >> 12601326

Pain intensity after laseruvulopalatoplasty and tonsillectomy.

Hannu Kokki1, Elina Nikanne, Mikko Aho, Jukka Virtaniemi.   

Abstract

OBJECTIVE: The first objective of this study was to evaluate pain intensity and opioid consumption during the first 24 hours after uvulopalatoplasty and tonsillectomy in the hospital, and the second was to evaluate pain intensity and its progression during the first 2 weeks after surgery at home. STUDY DESIGN AND SETTINGS: In a prospective parallel group study, 51 patients with uvulopalatoplasty or tonsillectomy were studied. Ketoprofen, a nonsteroidal antiinflammatory drug, and fentanyl citrate, an opioid, were used as analgesics.
RESULTS: Despite ketoprofen infusion and free access to a patient-controlled pump with fentanyl citrate for rescue analgesia, inadequate pain relief was common both after uvulopalatoplasty (35%) and after tonsillectomy (28%) during the first 24 hours after surgery. The consumption of fentanyl citrate was similar after both operations. At home, pain intensity was highest in the mornings during the first 5 days, and 10 patients had some pain still after 2 weeks. Also at home, high pain scores were reported commonly in both groups.
CONCLUSION: Significant pain after uvulopalatoplasty and tonsillectomy lasted for several days. Ketoprofen in the commercial capsule form proved to be too short acting for overnight pain relief. SIGNIFICANCE: Pain treatment in patients with uvulopalatoplasty and tonsillectomy should be improved to allow patients a peaceful recovery after surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601326     DOI: 10.1067/mhn.2003.82

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

1.  Complications of hyoid suspension in the treatment of obstructive sleep apnea syndrome.

Authors:  Wietske Richard; Ferdinand Timmer; Harm van Tinteren; Nico de Vries
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-18       Impact factor: 2.503

2.  The effects of one botulinum toxin type A (BTX-A) injection after UPPP.

Authors:  Tae Yong Yang; Tae Young Jang
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-27       Impact factor: 2.503

3.  Barbed reposition pharyngoplasty in multilevel robotic surgery for obstructive sleep apnoea.

Authors:  C Vicini; G Meccariello; G Cammaroto; M Rashwan; F Montevecchi
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-06       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.